INVESTOR LOGIN

LRG BayStar Capital Funds Portfolio

PORTFOLIO COMPANIES

Please find some the portfolio of current and prior LRG BayStar Capital Funds' portfolio companies below:

Introgen Therapeutics, Inc. (INGN)

Introgen Therapeutics, Inc. (INGN)

IIntrogen Therapeutics, Inc. develops gene therapy products for the treatment of cancer and other diseases.
http://www.introgen.com

LifeCell Corporation

LifeCell Corporation

LifeCell Corporation develops and markets biological products for the repair and replacement of damaged or inadequate human tissue in numerous clinical applications.
  http://www.lifecell.com

Lorus Therapeutics, Inc. (LRP)

Lorus Therapeutics, Inc. (LRP)

Lorus Therapeutics is a biopharmaceutical company that specializes in the development and commercialization of pharmaceutical products for cancer management.
  http://www.lorusthera.com

The Medicines Company (MDCO)

The Medicines Company (MDCO)

The Medicines Company seeks to acquire, develop, and commercialize selected pharmaceutical products in late stages of development.
http://www.themedicinescompany.com

Nabi Biopharmaceuticals, Inc. (NABI)

Nabi Biopharmaceuticals, Inc. (NABI)

Nabi Biopharmaceuticals has a broad product portfolio and significant R&D capabilities focused on the development and commercialization of drugs that prevent and treat infectious and autoimmune diseases.
 
 
http://www.nabi.com

 
Arque Capital
This website is for general informational purposes only and is not intended as a solicitation or offering for any investment product or service.
LRG Capital Group, in alliance with Arque Capital, Ltd. Member FINRA/SIPC